EUS-RFA PANCARDINAL-1 Trial
Phase 2
60
about 6.8 years
18+
1 site in TX
What this study is about
This trial is testing whether endoscopic ultrasound (EUS)-guided radiofrequency ablation (RFA) plus standard chemotherapy can be used to treat pancreatic ductal adenocarcinoma (PDAC). The treatment will be given before surgery, with the goal of shrinking or stopping cancer spread so that surgery might be less invasive and more effective.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Neoadjuvant Chemotherapy (NAC)
- 2.Use Endoscopic Ultrasound (EUS)-Guided Radiofrequency Ablation (RFA)
Participation Burden
What's physically and logistically required of participants.
Requires travel to a study site
How treatment is administered
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Secondary: Disease-free survival time, Radiographic treatment response as assessed by standard Response evaluation criteria in solid tumors (RECIST) criteria